Sedative practice in intensive care units: Results of a Maghrebian survey;Enquete Maghrebine multicentrique sur la sedation en reanimation

Tunisie Medicale

Volumn 83, Issue 11, 2005, Pages 657-663

  Souissi, Kamel ^a   Mestiri, Tahar ^a   Frikha, Nabil ^a   Rekik, Mohamed ^a   Mebazaa, Mhamed Sami ^a   Ben Ammar, Mohamed Salah ^a  

^a MONGI SLIM HOSPITAL   (Tunisia)

Author keywords

Benzodiazepine; Drug costs; Intensive care; Neuromuscular block; Opiates; Propofol; Sedation

Indexed keywords

ANALGESIC AGENT; ATRACURIUM; CLONIDINE; DIAZEPAM; FENTANYL; FLUNITRAZEPAM; KETAMINE; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PROPOFOL; SUFENTANIL; VECURONIUM;

ARTICLE; CLINICAL PROTOCOL; DISEASE MANAGEMENT; DRUG CHOICE; DRUG COST; ECONOMIC ASPECT; HUMAN; INTENSIVE CARE; PRIVATE HOSPITAL; SCORING SYSTEM; SEDATION; TEACHING HOSPITAL; TUNISIA;

ANALGESICS; ANESTHESIA; ANESTHETICS; ANESTHETICS, INTRAVENOUS; DRUG COSTS; FENTANYL; HOSPITALS, TEACHING; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTENSIVE CARE UNITS; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENTS; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE PRACTICE; PROPOFOL; TUNISIA;

EID: 30144434691     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. YOUNG C, KNUDSEN N, HILTON A, REVES J. Sedation in the intensive care unit. Crit Care Med 2000 28: 854-66.
2. MANTZ J, MERCADIER B, LAFANACHERE A. La sédation et l'analgésie en réanimation. Conférence d'actualisation SFAR 2001; 619-628.
3. JUDITH J, FRASER G, DOUGLAS B. Clinical practice guidelines for sustained use of sedative and analgesics in the critically ill adult. Crit Care Med 2002; 30 (N1): 119-41.
4. Société française d'anesthésie et de réanimation. Sédation, analgésie et curarisation en réanimation recommandations pour la pratique clinique. Paris: Elsevier 2000: 112.
5. MASCIA M, KOCH M, JOSEPH J. Pharmacoeconomic impact of rationnal use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med 2000; 28: 2300-6.
6. SHAFER A. Complications of sedation with midazolam in the intensive care unit and a comparaison with other sedative regimens. Crit Care Med 1998; 26: 947-56.
7. SWART E, VAN SCHIJINDEL, ROBERT J. Continuous infusion of Lorazepam versus Midazolam in patients in the intensive care unit: sedation with Lorazepam is easier to manage and is more cost effective. Crit Care Med 1999; 27: 1461-65.
8. SOLIMAN HM, MELOT C, VINCENT J. Sedative and analgesic practice in the intensive care unit: the results of a Europeen survey. Br J Anaesth 2001; 87: 186-92.
9. CHRISTENSEN BV, THUNEDBORG LP. Use of sedatives, analgesics and neuromuscular blocking agents in Danish ICUs. Intensive Care Med 1999; 25: 186-91.
10. RICARDO I, RABATIN J. Sedation during mechanical ventilation: A systematic review. Crit Care Med 2002: 30: 2644-8.
11. WALDAR B, ELIA N, HENZI I, ROMAND J, TRAMER M. A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: A qualitative and quantitative systematic review. Anesth Analg 2001; 92: 975-83.
12. CARRASCO G, MOLINA R, COSTA J et al. Propofol versus Midazolam in short, medium and log term sedation of critically ill patients. Chest 1993; 103: 557-64.
13. BARRIENTOS-VEGA R, MAR SCHANCHEZ M, MORALES G, et al. Prolonged sedation of critically ill patients with Midazolam or Propofol: impact on weaning and costs. Crit Care Med 1997; 25: 33-40.
14. CAMPS A, JOSE A, VAZQUEZ D, BORGES, JOSEFA P, LOPEZ E. Midazolam and 2% Propofol in long term sedation of traumatized, critically ill patients: Efficacity and safety comparaison. Crit Care Med 2000; 28: 3612-19.
15. BARRIENTOS R, SANCHEZ S, CARMEN M, RAFAEL C, MANUEL C. Pharmacoeconomic assessement of propofol 2% used for prolonged sedation. Crit Care Med 2001; 29: 317-22.
16. ASLAM H, XIAO-HUA W, HECTOR L, RICHARD H. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002; 96; 196-201.
17. MURDOCH S, COHEN A. Intensive care sedation: a review of current British practice. Intensive Care Med 2000; 26: 922-8.
18. MURRAY M, COWEN J, DEBLOCK H. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30: 142-156.
19. ALAN D, THOMAS S, ROBYN S, DONND P, GLENDA S, WILLIAM S. Effect of a nursing implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27: 2609-13.
20. BAIR N, BOBEK M, HOFFMAN-HOGG L, MION L, SLOMKA J, ARROLIGA A. Introduction of sedative, analgesic, and neuromuscular blocking agents guidelines in a medical intensive care unit: Physician and nurse adherence. Crit Care Med 2000; 28: 707-13.
21. JOHN PK, ANNE SP, MICHAEL FO, JESSE BH. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Fngl J Med 2000; 342: 1471-7.
22. ROBERT JW, SANDRA LK, VINCENT AO, MELISSA S, SUSAN JS, JOSEPH FD. Impact of intensive care unit (ICU) drug use on hospital costs: A descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003; 31: S17-S24.
23. EDBROOKE D, HIBBERT C. Cost determinants and economic assessement in the critical care setting. Curr Opin Crit Care 1999; 5: 316-23.
24. ANDREW FS. An update on cost effectiveness analysis in critical care. Curr Opin Crit Care 2002; 8: 337-43.
25. JACOBS P, EDBROOK D, HIBBERT C, FASSBENDER K, CORCORAN M. Descriptive patient data as an explanation for the variation in average daily cost in intensive care. Anesthesia 2001; 56: 643-47.
26. DONALD BC. Pharmacoeconomic investigations in intensive care. Currt Opin Crit Care 2001; 7: 460-63.
27. PERUZZI W. Sedation of the critically ill: goals, plans, and cost-effectiveness. Crit Care Med 1997; 25: 1942-3.